EORTC abstracts at ESMO 2018
15 Oct 2018
Results from a number of EORTC trials will be presented at ESMO2018 Congress in Munich, please see below the title and presenters of the presentations:
Oral Presentation
- An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23)- EORTC QLQ-BR45
Presentation Number: 193O
Tumour Group: Quality of Life
Speaker: Vesna Bjelic-Radisic (Germany)
Date: 20.10.2018 – Lecture Time: 11:00 – Location: Hall A2 – Room 18
Poster Discussion
- A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC – the ETOP and EORTC SPLENDOUR trial.
Presentation Number 1385PD
Tumour Group: Lung
Poster Presenter: Solange Peters (Switzerland)
Date: 21.10.2018 – Lecture Time 17:15 – Location: ICM – Room 13
- Health-related quality of life in randomized controlled trials: a systematic review of prognostic significance
Presentation Number: 1540PD
Tumour Group: Quality of Life
Speaker: Justyna Mierzynska (Belgium)
Date: 22.10.2018 – Lecture Time: 16:30 – Location: Hall B3 – Room 21
Poster Display Session
- Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): results from an EORTC led survey
Poster Board Number: 1106P
Tumour Group: Head & Neck
Poster Presenter: Sjoukje Oosting (The Netherlands)
Date: 21.10.2018 – Lecture Time: 13:05 – 13:05 – Location: Hall A3 – Poster Area Networking Hub
- Combined analysis of gene expression profiles in 2 preoperative trials with afatinib and cetuximab in head and neck squamous cell carcinoma
Poster Board Number: 1086P
Tumour Group: Head & Neck
Poster Presenter: Paolo Bossi (Italy)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
- Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: an international randomized double-blind phase 3 trial.
Poster Board Number: 1278P
Tumour Group: Quality of Life
Poster Presenter: Corneel Coens (Belgium)
Date: 21.10.2018 – Lecture Time: 13:05 – Location: Hall B3 – Poster Area
Related News
Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types
30 May 2023
Publication of 2022 EORTC Annual Report
25 May 2023
EORTC is supporting Clinical Trials Day on 20th May
19 May 2023
Studying long-term survivors of glioblastoma may pave the way to better treatment
10 May 2023
Three new EORTC clinical trials funded by the EU
24 Apr 2023
Important new results from EORTC to be presented at ESTRO 2023
14 Apr 2023
EORTC QLG proudly collaborates on the EUonQoL project
21 Mar 2023
HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer
22 Feb 2023
EORTC: Working towards “Closing the Care Gap”
2 Feb 2023
First international recommendations on the use of item libraries for patient-reported outcome measurement
31 Jan 2023
